New Long-Read Genetic Test Enables Faster and More Comprehensive Diagnosis of Rare Diseases
November 18, 2025
Background
Epidemiology
Anatomy
Pathophysiology
Etiology
Genetics
Prognostic Factors
Clinical History
Physical Examination
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Differential Diagnoses
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
Medication
Initial:
10
mg
Orally
every 12 hrs
Titrate to 10-30 mg per day
off-label:
40 - 80
mg
Tablet
Orally
once a day
and can be increased up to 240 mg orally per day
5 - 10
mg
Orally 
once a day
Note: allow 2 consecutive medication-free days each week
0.5
mg
Tablet
Oral
at bedtime
(increase up to 1.5 mg/day depending on tolerability)
70
mg
Solution
Subcutaneous (SC)
once a month
140 mg subcutaneous once a month may be required in some people (administered as 2 consecutive 70-mg subcutaneous doses)
Migraine Headache Prophylaxis :
2
mg
Orally 
twice a day; w/wo propanol
Indicated for the migraine preventive treatment:
225
mg
Solution
Subcutaneous (SC)
once every month
Alternative: 3 consecutive 225mg subcutaneous dosages of 675 mg every three months (quarterly)
Dose Adjustments
Hepatic impairment
Dedicated studies on the effects of hepatic impairment on fremanezumab have yet to be performed. The data analysis from clinical studies indicated no differences in the pharmacokinetics in patients with mild liver dysfunction
Renal impairment
The pharmacokinetics are not anticipated to be affected, and no specific studies have been done to examine renal impairment
Indicated for the preventive migraine treatment:
Initial dose: 240mg subcutaneous once a month
Maintenance dose: 120mg subcutaneously monthly once
75 mg orally every other day
10 - 25
mg
Orally 
at bedtime
10-400 mg Orally at bedtime dose range
For children >12 years:
0.5
mg
Tablet
Oral
at bedtime
(increase up to 1 mg/day depending on tolerability)
Age: >3 years and adolescents :
0.2 - 0.4
mg/kg/day
orally
divided 2 times a day; do not exceed 0.5 mg/kg/day
Future Trends
References

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
